Descargar PDF

Otros usuarios también vieron estos artículos

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak, Mustafa Gür, Ahmet Karataş, Süleyman Serdar Koca, Bünyamin Kısacık
10.1016/j.reuma.2023.11.004
Prevalence and impact of chronic joint diseases on the sexual sphere compared to a healthy population: A multicenter cross-sectional study Carlos Valera-Ribera, Juan José Alegre-Sancho, Àngels Martínez-Ferrer, Montserrat Robustillo-Villarino
10.1016/j.reuma.2025.501993
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice Jordi Gratacós-Masmitja, Emma Beltrán Catalán, José Luis Álvarez Vega, Ana Urruticoechea-Arana, Concepción Fito, Francisco Maceiras, Joaquín María Belzunegui Otano, Julia Fernández Melón, Eugenio Chamizo Carmona, Miguel Ángel Abad Hernández, Inmaculada Ros Vilamajó, Sonia Castro Oreiro, Eva Pascual Alfonso, Juan Carlos Torre Alonso
10.1016/j.reuma.2023.06.007